Nausea and Vomiting: Clinical Trials

19 trials for Nausea and Vomiting, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 2 recruiting, 2 terminated, 2 withdrawn. 19 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable19Completed 12, Recruiting 2, Terminated 2, Withdrawn 2, Unknown 1

Follow Nausea and Vomiting: new trials by email Literature Review of Nausea and Vomiting trials Research Report on Nausea and Vomiting

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dexmedetomidine and Propofol for Sedation in Cataract Surgery.
Dexmedetomidine (DEX), Propofol (PRO), Fentanyl (FEN) - Sedation, Cataract
Not applicableRecruitingSaint-Joseph University10002025-11-092026-04-29
Exploring the Effect of Aromatherapy
Aromatherapy plus standard of care, Standard of Care Only - Anxiety, Labor Pain
Not applicableCompletedBaptist Health South Florida1382025-10-152026-10-06
The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV
Palonosetron hydrochloride capsules - Nausea and Vomiting
Not applicableRecruitingXijing Hospital10602022-05-162023-01-19
The Impact of Oral Cryotherapy and Chewing Gum Interventions
Oral Cryotherapy Group (Group 1), Chewing Gum Group (Group 2) - Breast Cancer, Nausea and Vomiting
Not applicableCompletedHacettepe University1352021-06-012025-08-28
Comparison of the Effect of Ondansetron and Combined Ondansetron and Betahistine on Postoperative Nausea and Vomiting After Gynecological Laparoscopy
ondansetron, ondansetron-betahistine - Nausea and Vomiting
Not applicableCompletedYonsei University1682013-12-012019-03-28
Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension
ramosetron, ondansetron, placebo - Hypotension, Shivering
Not applicableUnknownSeoul National University Hospital1002012-08-012012-08-20
Healing Touch or Guided Imagery In Treating Pain, Fatigue, Nausea, and Anxiety in Patients Undergoing Chemotherapy
questionnaire administration, therapeutic touch, management of therapy complications - Anxiety Disorder, Fatigue
Not applicableCompletedWake Forest University Health Sciences2442012-02-012018-07-05
Supportive Intervention Programs Study
Yoga therapy, questionnaire administration, quality-of-life assessment - Fatigue, Nausea and Vomiting
Not applicableCompletedWake Forest University152011-06-012018-08-15
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
Adjuvant Therapy, Aprepitant, Carboplatin - Nausea and Vomiting, Ovarian Brenner Tumor
Not applicableTerminatedGynecologic Oncology Group42011-06-012018-05-22
Hypnosis in Reducing Pain and Other Side Effects in Women Undergoing Surgery for Breast Cancer
questionnaire administration, hypnotherapy, therapeutic conventional surgery - Anxiety Disorder, Breast Cancer
Not applicableCompletedCity of Hope Medical Center202008-08-012011-03-07
Nurse-Provided Care or Standard Care in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer
medical chart review, questionnaire administration, fatigue assessment and management - Breast Cancer, Fatigue
Not applicableWithdrawnCity of Hope Medical Center2008-07-012013-02-01
Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer
medical chart review, questionnaire administration, fatigue assessment and management - Fatigue, Nausea and Vomiting
Not applicableCompletedCity of Hope Medical Center1252008-07-012010-10-01
Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer
aprepitant, ondansetron hydrochloride - Myeloproliferative Disorders, Leukemia
Not applicableWithdrawnVanderbilt-Ingram Cancer Center2007-08-012013-04-02
Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy
Aprepitant, Dexamethasone, Dolasetron Mesylate - Malignant Digestive System Neoplasm, Nausea and Vomiting
Not applicableTerminatedUniversity of Southern California192006-04-192017-03-28
Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer
palonosetron hydrochloride, cyclophosphamide, dexamethasone - Male Breast Cancer, Nausea and Vomiting
Not applicableCompletedUniversity of Washington412006-01-012017-07-11
Acupressure in Preventing Nausea and Vomiting in Young Cancer Patients Receiving Chemotherapy
acupressure therapy, sham intervention - Nausea and Vomiting, Unspecified Childhood Solid Tumor, Protocol Specific
Not applicableCompletedWake Forest University Health Sciences282005-04-012018-08-10
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
Aprepitant, Cyclophosphamide, Dexamethasone - Breast Cancer, Chronic Myeloproliferative Disorders
Not applicableCompletedBarbara Ann Karmanos Cancer Institute402004-10-012016-03-15
Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer
Quality-of-Life Assessment, Yoga - Alopecia, Anxiety
Not applicableCompletedAlbert Einstein College of Medicine3992001-02-082023-05-31
Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy
ondansetron - Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
Not applicableCompletedUniversity of Rochester2000-08-012013-03-05

Narrower conditions

Nausea (19)  ·  Vomiting (19)  ·  Breast Neoplasms (6)  ·  Pain (6)  ·  Fatigue (5)  ·  Anxiety Disorders (4)  ·  Burkitt Lymphoma (2)  ·  Hodgkin Disease (2)  ·  Leukemia (2)  ·  Leukemia, Hairy Cell (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (2)  ·  Leukemia, Myelomonocytic, Chronic (2)  ·  Leukemia, Neutrophilic, Chronic (2)

Broader conditions

Pathological Conditions, Signs and Symptoms (19)  ·  Signs and Symptoms (19)  ·  Signs and Symptoms, Digestive (19)  ·  Neoplasms (11)  ·  Neoplasms by Site (11)  ·  Neurologic Manifestations (7)  ·  Breast Diseases (6)  ·  Skin Diseases (6)  ·  Skin and Connective Tissue Diseases (6)  ·  Cardiovascular Diseases (4)  ·  Digestive System Diseases (4)  ·  Digestive System Neoplasms (4)  ·  Mental Disorders (4)  ·  Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)

Interventions

Ondansetron (5)  ·  Aprepitant (4)  ·  Calcium Dobesilate (4)  ·  Dexamethasone (4)  ·  Therapeutics (3)  ·  dexamethasone 21-phosphate (3)  ·  dexamethasone acetate (3)  ·  Cyclophosphamide (2)  ·  Granisetron (2)  ·  Palonosetron (2)  ·  Psychiatric Rehabilitation (2)  ·  Yoga (2)  ·  auricularum (2)  ·  1,2-diaminocyclohexaneplatinum II citrate (1)  ·  Acupressure (1)

Sponsors

City of Hope Medical Center (3)  ·  Wake Forest University Health Sciences (2)  ·  Albert Einstein College of Medicine (1)  ·  Baptist Health South Florida (1)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Gynecologic Oncology Group (1)  ·  Hacettepe University (1)  ·  Saint-Joseph University (1)  ·  Seoul National University Hospital (1)  ·  University of Rochester (1)  ·  University of Southern California (1)  ·  University of Washington (1)  ·  Vanderbilt-Ingram Cancer Center (1)  ·  Wake Forest University (1)  ·  Xijing Hospital (1)

Countries

United States (12)  ·  South Korea (2)  ·  China (1)  ·  Lebanon (1)  ·  Turkey (Türkiye) (1)

Top investigators

Marcia Grant, RN, DNSc, FAAN (2)  ·  Alyson Moadel (1)  ·  Barbara A. Murphy, MD (1)  ·  Betty Chan (1)  ·  Gary R. Morrow, PhD, MS (1)  ·  Hannah Linden (1)  ·  Lisa Hodges (1)  ·  Liu Hong, master (1)  ·  Michael Lew, MD (1)  ·  Muneer H. Abidi, MD (1)  ·  Naji Abou Jalad, MD (1)  ·  Stephanie J Sohl, PhD (1)  ·  Steven Plaxe (1)  ·  Thomas Williams McLean, MD (1)

Results publications

PMID 17785709, PMID 19134445

NIH funding

P30CA033572 (3), P30CA013330 (1), P30CA014089 (1), P30CA022453 (1), R03CA088598 (1), U10CA101165 (1)